http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4719213-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553
filingDate 1986-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76736063d1578c38e1e0bd7537ea3974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e57b9c2413ef8e9afa6fcb51c4ea9ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_442a732b4ebd2f3b26f5216ece5ad8f5
publicationDate 1988-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4719213-A
titleOfInvention Anti-cancer composition for delivering 5-fluorouracil
abstract An anti-cancer composition for delivering a 5-fluorouracil to cancer tissues in a warm-blooded animal, wherein the cancer is a cancer sensitive to 5-fluorouracil. The composition comprises uracil or a pharmaceutically acceptable salt thereof, and a 5-fluorouracil pro drug selected from the group consisting of 1, 3-bis (2-tetrahydrofuryl)-5-fluorouracil and 3-(2-tetrahydrofuryl)-5-fluorouracil in a small amount of about 0.1 to less than 0.1 mole per mole of uracil or salt thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011262561-A1
priorityDate 1977-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5519244-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4371535-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4481203-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S557231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5699414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4328229-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4507301-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128594164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID125110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129575635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230771043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127864417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226563887

Total number of triples: 34.